On the other hand, it was also demonstrated that indomethacin, an indole-based COX-1 and COX-2 inhibitor, exhibited anti-lung cancer and anti-CRC activity through chemical modifications on the main structure [41,42,43,44,45]. The gene discussed is PTGS2; the disease is colorectal carcinoma.